| This 90-minute webinar provided an overview of how poison pills should be considered in connection with preparing for and/or responding to activist campaigns. Key topics covered included: |
- What are some of the scenarios where a poison pill would be considered in anticipation of, or in response to, an activist campaign?
- How can a poison pill be beneficial to an activist defense?
- What are the limitations of a poison pill when used in connection with a potential activist campaign?
- How is a poison pill adopted in connection with a potential activist campaign different from other poison pills?
- Should a “shelf” poison pill be part of a company’s preparedness planning for a potential activist campaign?
- What are some of the proxy advisory firm and other corporate governance issues to be concerned with when adopting a poison pill in connection with a potential activist campaign?
|
| About the Morgan Lewis Shareholder Activism Defense Practice |
| Morgan Lewis’s nationally recognized and rapid response shareholder activism defense practice is ranked near the top of most of the major league tables for activist defense law practices based on the number of publicly disclosed activism defense situations we have been involved in during the relevant period. Our shareholder activism defense practice advises public companies across the United States and abroad in a wide array of industries with respect to preparing for and/or responding to high-profile proxy contests, special meeting demands, consent solicitations, withhold campaigns, shareholder proposals, and other activist shareholder campaigns, as well as contests for corporate control and contested merger and acquisition situations. Our shareholder activism defense practice also advises on the latest techniques for lessening a company’s vulnerability to activist shareholders, strategic communications, shareholder engagement strategies, board composition enhancement programs, and corporate governance matters. |
|
|
|
